BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25388155)

  • 21. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.
    Schlette EJ; Medeiros LJ; Goy A; Lai R; Rassidakis GZ
    J Clin Oncol; 2004 May; 22(9):1682-8. PubMed ID: 15117990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.
    Samanta AK; Huang HJ; Le XF; Mao W; Lu KH; Bast RC; Liao WS
    Cancer; 2009 Sep; 115(17):3897-908. PubMed ID: 19517469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma.
    Kurose K; Sakaguchi M; Nasu Y; Ebara S; Kaku H; Kariyama R; Arao Y; Miyazaki M; Tsushima T; Namba M; Kumon H; Huh NH
    J Urol; 2004 Mar; 171(3):1314-8. PubMed ID: 14767340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome.
    Byun SS; Yeo WG; Lee SE; Lee E
    Urology; 2007 Jan; 69(1):34-7. PubMed ID: 17270609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
    Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
    Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
    Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
    Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
    Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
    Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
    J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEKK3-mediated signaling to p38 kinase and TonE in hypertonically stressed kidney cells.
    Padda R; Wamsley-Davis A; Gustin MC; Ross R; Yu C; Sheikh-Hamad D
    Am J Physiol Renal Physiol; 2006 Oct; 291(4):F874-81. PubMed ID: 16684924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
    Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
    Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
    He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
    Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?
    Masuda A; Kamai T; Abe H; Arai K; Yoshida K
    Biomed Res; 2009 Jun; 30(3):171-6. PubMed ID: 19574718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.